Search results
Author(s):
Martin Nicol
,
Mathilde Baudet
,
Alain Cohen-Solal
Added:
3 years ago
Advances in the early detection and treatment of cancer have improved overall survival in cancer patients. Nevertheless, cardiovascular diseases appear as the major cause of morbidity and mortality among cancer survivors.1 Left ventricular (LV) dysfunction and/or heart failure are the most common cardiovascular complications after administration of chemotherapies. The term ‘cardiotoxicity’ is…
View more
Author(s):
Radek Pudil
Added:
3 years ago
Cardiovascular (CV) disease and cancer remain the two most common causes of mortality in developed countries. According to recent data from the American Cancer Society, the lifetime probability of being diagnosed with an invasive cancer is higher for men (43 %) than for women (38 %).1 Within the last few decades the progress in the treatment of malignant diseases significantly improved survival…
View more
Heart Failure and Cancer
Author(s):
Alessandra Cuomo
,
Alessio Rodolico
,
Amalia Galdieri
,
et al
Added:
3 years ago
Article
Giselle Melendez
Research Area(s) / Expertise:
Job title: Assistant Professor
Author
Cardiac Toxicity of Cancer Chemotherapy
Author(s):
Aarti Asnani
Start date:
Aug 08, 2017
Broadcast
Author(s):
Carine E Hamo
,
Michelle W Bloom
Added:
3 years ago
Heart disease and cancer are the two leading causes of death, together accounting for almost 50 % of deaths in the US.1 Unfortunately, the tremendous success in improving cancer survival is often attenuated by downstream cardiovascular complications from cancer therapy. Acute cardiac toxicity may limit the ability to use life-saving cancer therapy and chronic toxicity limits overall survival. As…
View more
Author(s):
Edoardo Bertero
,
Pietro Ameri
,
Christoph Maack
Added:
3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular…
View more
Author(s):
Mark Sweeney
,
Angela Yiu
,
Alexander Lyon
Added:
3 years ago
Cancer and the anti-cancer treatments prescribed by oncologists have long been known to have significant effects on muscle, causing a catabolic muscle wasting state and resulting in widespread and progressive atrophy of most muscle groups.1 This process contributes significantly to the cancer cachexia seen in up to 80% of all patients with cancer, resulting in progressive weight loss, loss of…
View more
Daniel Chen
Job title: Consultant Cardiologist
Author